Navigation Links
DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant
Date:3/7/2013

083 represents a 'first in class' small-molecule chemotherapeutic. VAL-083 has been assessed in multiple NCI-sponsored clinical studies in various cancers including lung, brain, cervical, ovarian tumors and leukemia.  Published pre-clinical and clinical data suggest that VAL-083 may be active against a range of tumor types.  VAL-083 is approved as a cancer chemotherapeutic in China for the treatment of chronic myelogenous leukemia and lung cancer

Based on published research, the mechanism of action of VAL-083 is understood to be a bi-functional alkylating agent; however, the functional groups associated with alkylating events has been shown to differ from other alkylating agents used in the treatment of GBM.

VAL-083 has previously demonstrated activity in cyclophosphamide, BCNU and phenylanine mustard resistant cell lines and no evidence of cross-resistance has been encountered in published clinical studies.  Based on the presumed alkylating functionality of VAL-083, published literature suggests that DNA repair mechanisms associated with Temodar and nitrosourea resistance, such as 06-methylguanine methyltransferace (MGMT), may not confer resistance to VAL-083. 

VAL-083 readily crosses the blood brain barrier where it maintains a long half-life in comparison to the plasma.  Published preclinical and clinical research demonstrates that VAL-083 is selective for brain tumor tissue.

VAL-083 has been assessed in multiple studies as chemotherapy in the treatment of newly diagnosed and recurrent brain tumors.  In general, tumor regression was achieved following therapy in greater than 40% of patients treated and stabilization was achieved in an additional 20% - 30%.  In published clinical studies, VAL-083 has previously been shown to have a statistically significant impact on median survival in high grade gliomas when combined with radiation vs. radiation alone. 

The mai
'/>"/>

SOURCE DelMar Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
2. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
3. DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
4. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
5. AcelRx Pharmaceuticals to Hold Fourth Quarter 2012 Financial Results Conference Call and Webcast on March 12, 2013
6. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results
7. Inovio Pharmaceuticals Prices $15.1 Million Offering of Common Stock and Warrants
8. Receptos Determines Novel GPCR Structure, Achieves Key Milestone in Collaboration with Ono Pharmaceuticals
9. AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY
10. Cylene Pharmaceuticals and TetraGene Enter Agreement for Quarfloxin and Anticancer Quadruplex Technologies
11. Isis Pharmaceuticals to Present at the Barclays Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Sept. 15, 2014 Research and Markets ... (CAS 103-90-2) Market Research Report 2014" report to ... Market Research Report 2014 presents comprehensive data on paracetamol ... , Asia , North ... includes paracetamol (acetaminophen) description, covers its application areas and ...
(Date:9/15/2014)... 15, 2014  MedExpress Urgent Care, a national leader in ... flu shots for ages four and up at each of ... get their flu shot early. According to ... of June, making late summer and early fall an ideal ... Vice President of Provider and Clinical Quality, Thomas Pangburn ...
(Date:9/15/2014)... PLYMOUTH MEETING, Pa. , Sept. 15, 2014 /PRNewswire/ ... today that it has met the stringent listing criteria ... has transferred to this U.S. stock exchange from the ... its current ticker symbol, "INO." NASDAQ ... Market, maintains the highest initial listing standards of any ...
Breaking Medicine Technology:Paracetamol (Acetaminophen) (CAS 103-90-2) Market Research Report 2014 2Paracetamol (Acetaminophen) (CAS 103-90-2) Market Research Report 2014 3MedExpress Quotes Late Summer, Early Fall As Best Time to Receive Flu Shot 2Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange 2Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange 3
... TOPAZ Technologies, a leading provider of biomedical research ... ML Weekes & Company, a professional services firm ... strategic partnership.  As a result of this partnership, ... solution through ML Weekes & Company,s RAMS grantsERA ...
... Texas, Nov. 16, 2010 Argon Medical Devices, Inc. ... licensing agreement with Rex Medical, LP ("Rex Medical") for ... dialysis catheter ™ on a global basis. UltraStream ™ ... patients receiving dialysis treatments. Argon will be ...
Cached Medicine Technology:TOPAZ Technologies and ML Weekes & Company Announce Partnership 2TOPAZ Technologies and ML Weekes & Company Announce Partnership 3Argon Medical Devices Announces Exclusive License and Distribution Agreement for 'UltraStream™' Chronic Hemodialysis Catheter 2
(Date:9/16/2014)... (PRWEB) September 16, 2014 The rapidly ... concern for health plans, employers and PBMs as spending ... of their drug lists. Once a concentrated, patient-specific practice, ... 25 webinar from Atlantic Information Services, Inc. (AIS), ... will offer details of what one leading health ...
(Date:9/16/2014)... San Diego, CA (PRWEB) September 16, 2014 ... a new hydrating lip gloss that true-ly pampers lips from ... your lips satin-smooth all day. , “The creation of true ... were suffering from dry, dehydrated lips no matter what products ... that not only looked great on, but could actually hydrate ...
(Date:9/16/2014)... Triad Semiconductor, Inc. today announced that David ... former President of Linear Technology Corporation was appointed to ... technology and business expertise, and we are delighted that ... Hayden, Triad CEO and chairman. , Mr. Bell brings ... semiconductor experience to Triad's board. From 2008 to 2012, ...
(Date:9/15/2014)... St. Louis, Missouri (PRWEB) September 16, 2014 ... injury lawyers at Carey Danis & Lowe ... Boston Scientific Corp., was found responsible for the injuries ... their bladder sling to treat stress urinary incontinence (SUI). ... that practices defective medical device litigation and personal injury ...
(Date:9/15/2014)... 2014 iFitDress.com, one of the most distinguished ... sapphire evening dresses to its online store. In ... top quality products. They are now provided at very low ... senior spokesman has confidence in the newly unveiled sapphire evening ... by customers from all over the world. Up to now, ...
Breaking Medicine News(10 mins):Health News:Sept. 25 Webinar to Offer Health Plan, Employer Strategies to Control Compounded Medication Costs 2Health News:True Science Cosmetics, LLC Launches True Lipz™ 2Health News:David Bell Joins Triad Semiconductor's Board of Directors 2Health News:Carey Danis & Lowe Reports On $73 Million Boston Scientific Verdict 2Health News:Beautiful Sapphire Evening Dresses Provided By iFitDress.com 2
... trial finds better control of disease when chemo is targeted ... News) -- The number one cancer killer, lung cancer, may ... drugs to tumors with key genetic traits, a new study ... -- found that, overall, 46 percent of patients with stage ...
... ... successfully completed deployment of CellTrak workflow automation and visit compliance solutions. The result ... ... 18, 2010 -- ABC Hospice, Inc, a premier hospice provider in North East Alabama, ...
... , ... Touchstone Products LLC is proud to announce ... quality Infrared Saunas at affordable prices directly to the American Consumer. ... in the privacy of your home. Constructed from the highest ...
... ... in Trilogy Analytical Laboratory , ... Darmstadt, Germany (PRWEB) April 17, 2010 -- R-Biopharm AG, a leading developer ... that the company has purchased a majority ownership position in Trilogy Analytical Laboratory, Inc. ...
... along the U.S.-Mexico border frequently buy over-the-counter oral contraceptives ... and can send a friend to pick up the ... University of Texas campuses and Ibis Reproductive Health. ... there is demand in the United States for over-the-counter ...
... is available in French . , "It is high ... and help people who suffer from this disease," says Dr. Jean ... the Montreal Chest Institute of the MUHC, and lead investigator of ... Centre for Cardiovascular and Pulmonary Research, University of British Columbia. As ...
Cached Medicine News:Health News:Matching Tumor Types to Drugs Boosts Lung Cancer Outcomes 2Health News:Matching Tumor Types to Drugs Boosts Lung Cancer Outcomes 3Health News:CellTrak Increases Employee Productivity and Efficiencies at ABC Hospice, Inc. 2Health News:CellTrak Increases Employee Productivity and Efficiencies at ABC Hospice, Inc. 3Health News:Touchstone Saunas Goes Online to Provide Premium Quality Infrared Saunas 2Health News:R-Biopharm Group Purchases a Majority Ownership in Trilogy Lab, Expanding US Operations 2Health News:Convenience drives US women to buy over-the-counter contraception in Mexico, study finds 2Health News:MUHC leads pan-Canadian initiative on respiratory disease 2
... custom bars have a large body ... contacts (spaced 3 centimeters center-to-center) to ... repeated cleaning. Polarity indicators are molded ... handle fits our bar electrode styles. ...
... phakic IOL is the first lens of its ... for the reduction or elimination of myopia in ... diopters and in patients aged 21 and over. ... 150,000 procedures performed worldwide, results prove that the ...
... the strongest vacuum force in ... The unit includes a ... plug, footswitch, built-in wheels, retractable ... ring to hold the liquid ...
... technology for the phakic eye, clinically ... quality of vision and visual acuity ... lens is compatible with current cataract ... for the correction of myopia in ...
Medicine Products: